Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 134,986 251,929 319,053 656,089
Total Sell Value $11,097,511 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 9 19 27 56
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 1285
  Page 36 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-22 4 A $0.00 $0 D/D 44,520 235,194     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-03-22 4 A $0.00 $0 D/D 4,790 18,080     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2017-03-22 4 A $0.00 $0 D/D 12,200 26,671     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2017-03-22 4 A $0.00 $0 D/D 12,200 55,422     -
   Baffi Robert EVP, Technical Operations   •       –      –    2017-03-22 4 A $0.00 $0 D/D 11,870 147,491     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-03-16 4 D $90.96 $34,201 D/D (376) 13,290     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2017-03-16 4 AS $91.96 $182,908 D/D (1,989) 14,471     -
   Davis George Eric EVP, General Counsel   •       –      –    2017-03-16 4 AS $91.96 $205,806 D/D (2,238) 73,729     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-16 4 AS $91.96 $459,800 D/D (5,000) 190,674     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-16 4 OE $71.33 $356,650 D/D 5,000 195,674     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2017-03-15 4 D $92.50 $473,230 D/D (5,116) 120,402     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2017-03-15 4 D $92.50 $304,140 D/D (3,288) 43,222     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2017-03-15 4 D $92.50 $31,080 D/D (336) 13,666     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2017-03-15 4 D $92.50 $397,843 D/D (4,301) 16,460     -
   Baffi Robert EVP, Technical Operations   •       –      –    2017-03-15 4 D $92.50 $304,233 D/D (3,289) 135,621     -
   Davis George Eric EVP, General Counsel   •       –      –    2017-03-15 4 D $92.50 $277,038 D/D (2,995) 75,967     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-15 4 D $92.50 $1,451,325 D/D (15,690) 190,674     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-15 4 AS $91.42 $457,100 D/D (5,000) 206,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-15 4 OE $17.33 $86,650 D/D 5,000 211,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-13 4 AS $92.68 $463,400 D/D (5,000) 206,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-13 4 OE $17.33 $86,650 D/D 5,000 211,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-10 4 AS $91.09 $455,450 D/D (5,000) 206,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-10 4 OE $17.33 $86,650 D/D 5,000 211,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-09 4 AS $90.18 $541,080 D/D (6,000) 206,364     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2017-03-09 4 OE $17.33 $103,980 D/D 6,000 212,364     -
  1285 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 36 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us